Study to Assess Safety and Efficacy of ELAD in Subjects With Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure

This study has been terminated.
(Due to results from the 1st pivotal study, the ELAD clinical plan is being re-evaluated, and the VTI-210 study has been terminated.)
Information provided by (Responsible Party):
Vital Therapies, Inc. Identifier:
First received: April 8, 2013
Last updated: October 20, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)
No publications provided by Vital Therapies, Inc.

Publications automatically indexed to this study by Identifier (NCT Number):